Managers

Emerging manager roundup: Base, Strategic Healthcare and DSG lead quiet two weeks

Emerging venture managers entered September and activity was sparse, as only five emerging managers raised commitments in previous two weeks.

March Capital targets $410 mln for third fund

March Capital Partners is seeking to raise $410 million for its third fund, according to an SEC filing. The Santa Monica, California-based venture firm invests in technology.

Arrowroot collects $62 mln for fourth fund

Arrowroot Capital has raised $62 million for its fourth fund, according to an SEC filing. The target is $315 million. Santa Monica, California-based Arrowroot Capital Management is a growth equity firm that invests in B2B software firms.

VC-backed Rgenix appoints new chief medical officer

New York City-based Rgenix Inc, a developer of first-in-class small molecule and antibody cancer therapeutics, has named Dr. Robert Wasserman as its new chief medical officer. Recently, Wasserman was chief medical officer at Toronto-based Northern Biologics, a developer of first-in-class immuno-oncology products. Rgenix's backers include Lepu Medical, Oceanpine Capital, WuXi AppTec’s Corporate Venture Fund, Novo Holdings A/S, Sofinnova Partners, Alexandria Venture Investments LLC and the Partnership Fund for New York City.

VC-backed Verve Therapeutics expands scientific advisory board with new addition

Cambridge, Massachusetts-based Verve Therapeutics, a next-generation cardiovascular company, has named Dr. Andrew Geall to its scientific advisory board. Geall is vice president of formulations, analytics and chemistry at Avidity Biosciences. Verve's backers include GV, ARCH Venture Partners, F-Prime Capital and Biomatics Capital.

Miami’s venture ecosystem is trying hard to grow up

South Florida has an active first half, with VC activity already surpassing all of last year for the Miami metro area.

SV Tech Ventures gathers over $23.1 mln for third fund

SV Tech Ventures has raised over $23.1 million for its third fund, according to an SEC filing. The target is $100 million. Based in Palo Alto, California, the venture firm focuses on high-tech companies.

Friday Letter: How Tim Smith of Bee Partners helps founders

A weekly letter from the VCJ editor about an assortment of what's happening in VC, along with who we're meeting and what we're hearing

In Canada, 11 percent of H1 VC investments go to agriculture

Protectionism and increased scrutiny of foreign investment into the US encourage investors to look at Canada, as appetite for direct institutional investment also grows.

Arcadian nets over $21.8 mln for new venture fund

Arcadian Capital Management has raised over $21.8 million for its new venture fund, according to an SEC filing. The target is $50 million. Based in Beverly Hills, California, Arcadian invests in the ancillary cannabis industry.